 | • レポートコード：MRC308GR11460 • 出版社/出版日：GlobalInfoResearch / 2023年8月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界のメチルプレドニゾロン製剤の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のメチルプレドニゾロン製剤市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– メチルプレドニゾロン製剤の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
メチルプレドニゾロン製剤市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・錠剤、注射剤
用途別セグメント
・病院、診療所、その他
主要な市場プレーヤー
・Pfizer、Sandoz、Hikma Pharmaceuticals、Teva Pharmaceutical、Lupin、Zydus Pharmaceuticals、Sinopharm Group Rongsheng Pharmaceutical、Tianjin Tianyao Pharmaceuticals、Liaoning Haisco Pharmaceutical、Nang Kuang Pharmaceutical、Chongqing Huapont Pharmaceutical、Zhejiang Xianju Pharmaceutical、Fuan Pharmaceutical
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、メチルプレドニゾロン製剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なメチルプレドニゾロン製剤メーカーの企業概要、2019年～2022年までのメチルプレドニゾロン製剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なメチルプレドニゾロン製剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別メチルプレドニゾロン製剤の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのメチルプレドニゾロン製剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのメチルプレドニゾロン製剤市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびメチルプレドニゾロン製剤の産業チェーンを掲載しています。
・第14、15章では、メチルプレドニゾロン製剤の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– メチルプレドニゾロン製剤の概要
– 種類別分析（2018年vs2022年vs2029年）：錠剤、注射剤
– 用途別分析（2018年vs2022年vs2029年）：病院、診療所、その他
– 世界のメチルプレドニゾロン製剤市場規模・予測
– 世界のメチルプレドニゾロン製剤生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Pfizer、Sandoz、Hikma Pharmaceuticals、Teva Pharmaceutical、Lupin、Zydus Pharmaceuticals、Sinopharm Group Rongsheng Pharmaceutical、Tianjin Tianyao Pharmaceuticals、Liaoning Haisco Pharmaceutical、Nang Kuang Pharmaceutical、Chongqing Huapont Pharmaceutical、Zhejiang Xianju Pharmaceutical、Fuan Pharmaceutical
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：錠剤、注射剤
・用途別分析2018年-2029年：病院、診療所、その他
・メチルプレドニゾロン製剤の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・メチルプレドニゾロン製剤のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・メチルプレドニゾロン製剤のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・メチルプレドニゾロン製剤の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・メチルプレドニゾロン製剤の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Methylprednisolone Preparations
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Methylprednisolone Preparations Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Tablets
1.3.3 Injection
1.4 Market Analysis by Application
1.4.1 Overview: Global Methylprednisolone Preparations Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Methylprednisolone Preparations Market Size & Forecast
1.5.1 Global Methylprednisolone Preparations Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Methylprednisolone Preparations Sales Quantity (2018-2029)
1.5.3 Global Methylprednisolone Preparations Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Methylprednisolone Preparations Product and Services
2.1.4 Pfizer Methylprednisolone Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Recent Developments/Updates
2.2 Sandoz
2.2.1 Sandoz Details
2.2.2 Sandoz Major Business
2.2.3 Sandoz Methylprednisolone Preparations Product and Services
2.2.4 Sandoz Methylprednisolone Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Sandoz Recent Developments/Updates
2.3 Hikma Pharmaceuticals
2.3.1 Hikma Pharmaceuticals Details
2.3.2 Hikma Pharmaceuticals Major Business
2.3.3 Hikma Pharmaceuticals Methylprednisolone Preparations Product and Services
2.3.4 Hikma Pharmaceuticals Methylprednisolone Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Hikma Pharmaceuticals Recent Developments/Updates
2.4 Teva Pharmaceutical
2.4.1 Teva Pharmaceutical Details
2.4.2 Teva Pharmaceutical Major Business
2.4.3 Teva Pharmaceutical Methylprednisolone Preparations Product and Services
2.4.4 Teva Pharmaceutical Methylprednisolone Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Teva Pharmaceutical Recent Developments/Updates
2.5 Lupin
2.5.1 Lupin Details
2.5.2 Lupin Major Business
2.5.3 Lupin Methylprednisolone Preparations Product and Services
2.5.4 Lupin Methylprednisolone Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Lupin Recent Developments/Updates
2.6 Zydus Pharmaceuticals
2.6.1 Zydus Pharmaceuticals Details
2.6.2 Zydus Pharmaceuticals Major Business
2.6.3 Zydus Pharmaceuticals Methylprednisolone Preparations Product and Services
2.6.4 Zydus Pharmaceuticals Methylprednisolone Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Zydus Pharmaceuticals Recent Developments/Updates
2.7 Sinopharm Group Rongsheng Pharmaceutical
2.7.1 Sinopharm Group Rongsheng Pharmaceutical Details
2.7.2 Sinopharm Group Rongsheng Pharmaceutical Major Business
2.7.3 Sinopharm Group Rongsheng Pharmaceutical Methylprednisolone Preparations Product and Services
2.7.4 Sinopharm Group Rongsheng Pharmaceutical Methylprednisolone Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Sinopharm Group Rongsheng Pharmaceutical Recent Developments/Updates
2.8 Tianjin Tianyao Pharmaceuticals
2.8.1 Tianjin Tianyao Pharmaceuticals Details
2.8.2 Tianjin Tianyao Pharmaceuticals Major Business
2.8.3 Tianjin Tianyao Pharmaceuticals Methylprednisolone Preparations Product and Services
2.8.4 Tianjin Tianyao Pharmaceuticals Methylprednisolone Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Tianjin Tianyao Pharmaceuticals Recent Developments/Updates
2.9 Liaoning Haisco Pharmaceutical
2.9.1 Liaoning Haisco Pharmaceutical Details
2.9.2 Liaoning Haisco Pharmaceutical Major Business
2.9.3 Liaoning Haisco Pharmaceutical Methylprednisolone Preparations Product and Services
2.9.4 Liaoning Haisco Pharmaceutical Methylprednisolone Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Liaoning Haisco Pharmaceutical Recent Developments/Updates
2.10 Nang Kuang Pharmaceutical
2.10.1 Nang Kuang Pharmaceutical Details
2.10.2 Nang Kuang Pharmaceutical Major Business
2.10.3 Nang Kuang Pharmaceutical Methylprednisolone Preparations Product and Services
2.10.4 Nang Kuang Pharmaceutical Methylprednisolone Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Nang Kuang Pharmaceutical Recent Developments/Updates
2.11 Chongqing Huapont Pharmaceutical
2.11.1 Chongqing Huapont Pharmaceutical Details
2.11.2 Chongqing Huapont Pharmaceutical Major Business
2.11.3 Chongqing Huapont Pharmaceutical Methylprednisolone Preparations Product and Services
2.11.4 Chongqing Huapont Pharmaceutical Methylprednisolone Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Chongqing Huapont Pharmaceutical Recent Developments/Updates
2.12 Zhejiang Xianju Pharmaceutical
2.12.1 Zhejiang Xianju Pharmaceutical Details
2.12.2 Zhejiang Xianju Pharmaceutical Major Business
2.12.3 Zhejiang Xianju Pharmaceutical Methylprednisolone Preparations Product and Services
2.12.4 Zhejiang Xianju Pharmaceutical Methylprednisolone Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Zhejiang Xianju Pharmaceutical Recent Developments/Updates
2.13 Fuan Pharmaceutical
2.13.1 Fuan Pharmaceutical Details
2.13.2 Fuan Pharmaceutical Major Business
2.13.3 Fuan Pharmaceutical Methylprednisolone Preparations Product and Services
2.13.4 Fuan Pharmaceutical Methylprednisolone Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Fuan Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Methylprednisolone Preparations by Manufacturer
3.1 Global Methylprednisolone Preparations Sales Quantity by Manufacturer (2018-2023)
3.2 Global Methylprednisolone Preparations Revenue by Manufacturer (2018-2023)
3.3 Global Methylprednisolone Preparations Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Methylprednisolone Preparations by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Methylprednisolone Preparations Manufacturer Market Share in 2022
3.4.2 Top 6 Methylprednisolone Preparations Manufacturer Market Share in 2022
3.5 Methylprednisolone Preparations Market: Overall Company Footprint Analysis
3.5.1 Methylprednisolone Preparations Market: Region Footprint
3.5.2 Methylprednisolone Preparations Market: Company Product Type Footprint
3.5.3 Methylprednisolone Preparations Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Methylprednisolone Preparations Market Size by Region
4.1.1 Global Methylprednisolone Preparations Sales Quantity by Region (2018-2029)
4.1.2 Global Methylprednisolone Preparations Consumption Value by Region (2018-2029)
4.1.3 Global Methylprednisolone Preparations Average Price by Region (2018-2029)
4.2 North America Methylprednisolone Preparations Consumption Value (2018-2029)
4.3 Europe Methylprednisolone Preparations Consumption Value (2018-2029)
4.4 Asia-Pacific Methylprednisolone Preparations Consumption Value (2018-2029)
4.5 South America Methylprednisolone Preparations Consumption Value (2018-2029)
4.6 Middle East and Africa Methylprednisolone Preparations Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Methylprednisolone Preparations Sales Quantity by Type (2018-2029)
5.2 Global Methylprednisolone Preparations Consumption Value by Type (2018-2029)
5.3 Global Methylprednisolone Preparations Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Methylprednisolone Preparations Sales Quantity by Application (2018-2029)
6.2 Global Methylprednisolone Preparations Consumption Value by Application (2018-2029)
6.3 Global Methylprednisolone Preparations Average Price by Application (2018-2029)
7 North America
7.1 North America Methylprednisolone Preparations Sales Quantity by Type (2018-2029)
7.2 North America Methylprednisolone Preparations Sales Quantity by Application (2018-2029)
7.3 North America Methylprednisolone Preparations Market Size by Country
7.3.1 North America Methylprednisolone Preparations Sales Quantity by Country (2018-2029)
7.3.2 North America Methylprednisolone Preparations Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Methylprednisolone Preparations Sales Quantity by Type (2018-2029)
8.2 Europe Methylprednisolone Preparations Sales Quantity by Application (2018-2029)
8.3 Europe Methylprednisolone Preparations Market Size by Country
8.3.1 Europe Methylprednisolone Preparations Sales Quantity by Country (2018-2029)
8.3.2 Europe Methylprednisolone Preparations Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Methylprednisolone Preparations Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Methylprednisolone Preparations Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Methylprednisolone Preparations Market Size by Region
9.3.1 Asia-Pacific Methylprednisolone Preparations Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Methylprednisolone Preparations Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Methylprednisolone Preparations Sales Quantity by Type (2018-2029)
10.2 South America Methylprednisolone Preparations Sales Quantity by Application (2018-2029)
10.3 South America Methylprednisolone Preparations Market Size by Country
10.3.1 South America Methylprednisolone Preparations Sales Quantity by Country (2018-2029)
10.3.2 South America Methylprednisolone Preparations Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Methylprednisolone Preparations Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Methylprednisolone Preparations Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Methylprednisolone Preparations Market Size by Country
11.3.1 Middle East & Africa Methylprednisolone Preparations Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Methylprednisolone Preparations Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Methylprednisolone Preparations Market Drivers
12.2 Methylprednisolone Preparations Market Restraints
12.3 Methylprednisolone Preparations Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Methylprednisolone Preparations and Key Manufacturers
13.2 Manufacturing Costs Percentage of Methylprednisolone Preparations
13.3 Methylprednisolone Preparations Production Process
13.4 Methylprednisolone Preparations Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Methylprednisolone Preparations Typical Distributors
14.3 Methylprednisolone Preparations Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Methylprednisolone Preparations Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Methylprednisolone Preparations Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Methylprednisolone Preparations Product and Services
Table 6. Pfizer Methylprednisolone Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Pfizer Recent Developments/Updates
Table 8. Sandoz Basic Information, Manufacturing Base and Competitors
Table 9. Sandoz Major Business
Table 10. Sandoz Methylprednisolone Preparations Product and Services
Table 11. Sandoz Methylprednisolone Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Sandoz Recent Developments/Updates
Table 13. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Hikma Pharmaceuticals Major Business
Table 15. Hikma Pharmaceuticals Methylprednisolone Preparations Product and Services
Table 16. Hikma Pharmaceuticals Methylprednisolone Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Hikma Pharmaceuticals Recent Developments/Updates
Table 18. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 19. Teva Pharmaceutical Major Business
Table 20. Teva Pharmaceutical Methylprednisolone Preparations Product and Services
Table 21. Teva Pharmaceutical Methylprednisolone Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Teva Pharmaceutical Recent Developments/Updates
Table 23. Lupin Basic Information, Manufacturing Base and Competitors
Table 24. Lupin Major Business
Table 25. Lupin Methylprednisolone Preparations Product and Services
Table 26. Lupin Methylprednisolone Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Lupin Recent Developments/Updates
Table 28. Zydus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 29. Zydus Pharmaceuticals Major Business
Table 30. Zydus Pharmaceuticals Methylprednisolone Preparations Product and Services
Table 31. Zydus Pharmaceuticals Methylprednisolone Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Zydus Pharmaceuticals Recent Developments/Updates
Table 33. Sinopharm Group Rongsheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. Sinopharm Group Rongsheng Pharmaceutical Major Business
Table 35. Sinopharm Group Rongsheng Pharmaceutical Methylprednisolone Preparations Product and Services
Table 36. Sinopharm Group Rongsheng Pharmaceutical Methylprednisolone Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Sinopharm Group Rongsheng Pharmaceutical Recent Developments/Updates
Table 38. Tianjin Tianyao Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 39. Tianjin Tianyao Pharmaceuticals Major Business
Table 40. Tianjin Tianyao Pharmaceuticals Methylprednisolone Preparations Product and Services
Table 41. Tianjin Tianyao Pharmaceuticals Methylprednisolone Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Tianjin Tianyao Pharmaceuticals Recent Developments/Updates
Table 43. Liaoning Haisco Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Liaoning Haisco Pharmaceutical Major Business
Table 45. Liaoning Haisco Pharmaceutical Methylprednisolone Preparations Product and Services
Table 46. Liaoning Haisco Pharmaceutical Methylprednisolone Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Liaoning Haisco Pharmaceutical Recent Developments/Updates
Table 48. Nang Kuang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 49. Nang Kuang Pharmaceutical Major Business
Table 50. Nang Kuang Pharmaceutical Methylprednisolone Preparations Product and Services
Table 51. Nang Kuang Pharmaceutical Methylprednisolone Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Nang Kuang Pharmaceutical Recent Developments/Updates
Table 53. Chongqing Huapont Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 54. Chongqing Huapont Pharmaceutical Major Business
Table 55. Chongqing Huapont Pharmaceutical Methylprednisolone Preparations Product and Services
Table 56. Chongqing Huapont Pharmaceutical Methylprednisolone Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Chongqing Huapont Pharmaceutical Recent Developments/Updates
Table 58. Zhejiang Xianju Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 59. Zhejiang Xianju Pharmaceutical Major Business
Table 60. Zhejiang Xianju Pharmaceutical Methylprednisolone Preparations Product and Services
Table 61. Zhejiang Xianju Pharmaceutical Methylprednisolone Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Zhejiang Xianju Pharmaceutical Recent Developments/Updates
Table 63. Fuan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 64. Fuan Pharmaceutical Major Business
Table 65. Fuan Pharmaceutical Methylprednisolone Preparations Product and Services
Table 66. Fuan Pharmaceutical Methylprednisolone Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Fuan Pharmaceutical Recent Developments/Updates
Table 68. Global Methylprednisolone Preparations Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 69. Global Methylprednisolone Preparations Revenue by Manufacturer (2018-2023) & (USD Million)
Table 70. Global Methylprednisolone Preparations Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 71. Market Position of Manufacturers in Methylprednisolone Preparations, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 72. Head Office and Methylprednisolone Preparations Production Site of Key Manufacturer
Table 73. Methylprednisolone Preparations Market: Company Product Type Footprint
Table 74. Methylprednisolone Preparations Market: Company Product Application Footprint
Table 75. Methylprednisolone Preparations New Market Entrants and Barriers to Market Entry
Table 76. Methylprednisolone Preparations Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Methylprednisolone Preparations Sales Quantity by Region (2018-2023) & (K Units)
Table 78. Global Methylprednisolone Preparations Sales Quantity by Region (2024-2029) & (K Units)
Table 79. Global Methylprednisolone Preparations Consumption Value by Region (2018-2023) & (USD Million)
Table 80. Global Methylprednisolone Preparations Consumption Value by Region (2024-2029) & (USD Million)
Table 81. Global Methylprednisolone Preparations Average Price by Region (2018-2023) & (US$/Unit)
Table 82. Global Methylprednisolone Preparations Average Price by Region (2024-2029) & (US$/Unit)
Table 83. Global Methylprednisolone Preparations Sales Quantity by Type (2018-2023) & (K Units)
Table 84. Global Methylprednisolone Preparations Sales Quantity by Type (2024-2029) & (K Units)
Table 85. Global Methylprednisolone Preparations Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Global Methylprednisolone Preparations Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Global Methylprednisolone Preparations Average Price by Type (2018-2023) & (US$/Unit)
Table 88. Global Methylprednisolone Preparations Average Price by Type (2024-2029) & (US$/Unit)
Table 89. Global Methylprednisolone Preparations Sales Quantity by Application (2018-2023) & (K Units)
Table 90. Global Methylprednisolone Preparations Sales Quantity by Application (2024-2029) & (K Units)
Table 91. Global Methylprednisolone Preparations Consumption Value by Application (2018-2023) & (USD Million)
Table 92. Global Methylprednisolone Preparations Consumption Value by Application (2024-2029) & (USD Million)
Table 93. Global Methylprednisolone Preparations Average Price by Application (2018-2023) & (US$/Unit)
Table 94. Global Methylprednisolone Preparations Average Price by Application (2024-2029) & (US$/Unit)
Table 95. North America Methylprednisolone Preparations Sales Quantity by Type (2018-2023) & (K Units)
Table 96. North America Methylprednisolone Preparations Sales Quantity by Type (2024-2029) & (K Units)
Table 97. North America Methylprednisolone Preparations Sales Quantity by Application (2018-2023) & (K Units)
Table 98. North America Methylprednisolone Preparations Sales Quantity by Application (2024-2029) & (K Units)
Table 99. North America Methylprednisolone Preparations Sales Quantity by Country (2018-2023) & (K Units)
Table 100. North America Methylprednisolone Preparations Sales Quantity by Country (2024-2029) & (K Units)
Table 101. North America Methylprednisolone Preparations Consumption Value by Country (2018-2023) & (USD Million)
Table 102. North America Methylprednisolone Preparations Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Europe Methylprednisolone Preparations Sales Quantity by Type (2018-2023) & (K Units)
Table 104. Europe Methylprednisolone Preparations Sales Quantity by Type (2024-2029) & (K Units)
Table 105. Europe Methylprednisolone Preparations Sales Quantity by Application (2018-2023) & (K Units)
Table 106. Europe Methylprednisolone Preparations Sales Quantity by Application (2024-2029) & (K Units)
Table 107. Europe Methylprednisolone Preparations Sales Quantity by Country (2018-2023) & (K Units)
Table 108. Europe Methylprednisolone Preparations Sales Quantity by Country (2024-2029) & (K Units)
Table 109. Europe Methylprednisolone Preparations Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Methylprednisolone Preparations Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Methylprednisolone Preparations Sales Quantity by Type (2018-2023) & (K Units)
Table 112. Asia-Pacific Methylprednisolone Preparations Sales Quantity by Type (2024-2029) & (K Units)
Table 113. Asia-Pacific Methylprednisolone Preparations Sales Quantity by Application (2018-2023) & (K Units)
Table 114. Asia-Pacific Methylprednisolone Preparations Sales Quantity by Application (2024-2029) & (K Units)
Table 115. Asia-Pacific Methylprednisolone Preparations Sales Quantity by Region (2018-2023) & (K Units)
Table 116. Asia-Pacific Methylprednisolone Preparations Sales Quantity by Region (2024-2029) & (K Units)
Table 117. Asia-Pacific Methylprednisolone Preparations Consumption Value by Region (2018-2023) & (USD Million)
Table 118. Asia-Pacific Methylprednisolone Preparations Consumption Value by Region (2024-2029) & (USD Million)
Table 119. South America Methylprednisolone Preparations Sales Quantity by Type (2018-2023) & (K Units)
Table 120. South America Methylprednisolone Preparations Sales Quantity by Type (2024-2029) & (K Units)
Table 121. South America Methylprednisolone Preparations Sales Quantity by Application (2018-2023) & (K Units)
Table 122. South America Methylprednisolone Preparations Sales Quantity by Application (2024-2029) & (K Units)
Table 123. South America Methylprednisolone Preparations Sales Quantity by Country (2018-2023) & (K Units)
Table 124. South America Methylprednisolone Preparations Sales Quantity by Country (2024-2029) & (K Units)
Table 125. South America Methylprednisolone Preparations Consumption Value by Country (2018-2023) & (USD Million)
Table 126. South America Methylprednisolone Preparations Consumption Value by Country (2024-2029) & (USD Million)
Table 127. Middle East & Africa Methylprednisolone Preparations Sales Quantity by Type (2018-2023) & (K Units)
Table 128. Middle East & Africa Methylprednisolone Preparations Sales Quantity by Type (2024-2029) & (K Units)
Table 129. Middle East & Africa Methylprednisolone Preparations Sales Quantity by Application (2018-2023) & (K Units)
Table 130. Middle East & Africa Methylprednisolone Preparations Sales Quantity by Application (2024-2029) & (K Units)
Table 131. Middle East & Africa Methylprednisolone Preparations Sales Quantity by Region (2018-2023) & (K Units)
Table 132. Middle East & Africa Methylprednisolone Preparations Sales Quantity by Region (2024-2029) & (K Units)
Table 133. Middle East & Africa Methylprednisolone Preparations Consumption Value by Region (2018-2023) & (USD Million)
Table 134. Middle East & Africa Methylprednisolone Preparations Consumption Value by Region (2024-2029) & (USD Million)
Table 135. Methylprednisolone Preparations Raw Material
Table 136. Key Manufacturers of Methylprednisolone Preparations Raw Materials
Table 137. Methylprednisolone Preparations Typical Distributors
Table 138. Methylprednisolone Preparations Typical Customers
List of Figures
Figure 1. Methylprednisolone Preparations Picture
Figure 2. Global Methylprednisolone Preparations Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Methylprednisolone Preparations Consumption Value Market Share by Type in 2022
Figure 4. Tablets Examples
Figure 5. Injection Examples
Figure 6. Global Methylprednisolone Preparations Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Methylprednisolone Preparations Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Other Examples
Figure 11. Global Methylprednisolone Preparations Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Methylprednisolone Preparations Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Methylprednisolone Preparations Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Methylprednisolone Preparations Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Methylprednisolone Preparations Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Methylprednisolone Preparations Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Methylprednisolone Preparations by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Methylprednisolone Preparations Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Methylprednisolone Preparations Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Methylprednisolone Preparations Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Methylprednisolone Preparations Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Methylprednisolone Preparations Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Methylprednisolone Preparations Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Methylprednisolone Preparations Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Methylprednisolone Preparations Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Methylprednisolone Preparations Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Methylprednisolone Preparations Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Methylprednisolone Preparations Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Methylprednisolone Preparations Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Methylprednisolone Preparations Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Methylprednisolone Preparations Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Methylprednisolone Preparations Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Methylprednisolone Preparations Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Methylprednisolone Preparations Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Methylprednisolone Preparations Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Methylprednisolone Preparations Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Methylprednisolone Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Methylprednisolone Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Methylprednisolone Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Methylprednisolone Preparations Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Methylprednisolone Preparations Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Methylprednisolone Preparations Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Methylprednisolone Preparations Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Methylprednisolone Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Methylprednisolone Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Methylprednisolone Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Methylprednisolone Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Methylprednisolone Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Methylprednisolone Preparations Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Methylprednisolone Preparations Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Methylprednisolone Preparations Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Methylprednisolone Preparations Consumption Value Market Share by Region (2018-2029)
Figure 53. China Methylprednisolone Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Methylprednisolone Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Methylprednisolone Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Methylprednisolone Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Methylprednisolone Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Methylprednisolone Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Methylprednisolone Preparations Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Methylprednisolone Preparations Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Methylprednisolone Preparations Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Methylprednisolone Preparations Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Methylprednisolone Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Methylprednisolone Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Methylprednisolone Preparations Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Methylprednisolone Preparations Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Methylprednisolone Preparations Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Methylprednisolone Preparations Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Methylprednisolone Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Methylprednisolone Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Methylprednisolone Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Methylprednisolone Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Methylprednisolone Preparations Market Drivers
Figure 74. Methylprednisolone Preparations Market Restraints
Figure 75. Methylprednisolone Preparations Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Methylprednisolone Preparations in 2022
Figure 78. Manufacturing Process Analysis of Methylprednisolone Preparations
Figure 79. Methylprednisolone Preparations Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
| 【メチルプレドニゾロン製剤について】 ※メチルプレドニゾロン製剤は、合成コルチコステロイドの一種であり、主に抗炎症作用や免疫抑制作用を有する医薬品です。この製剤は、さまざまな疾患や症状の治療に利用されており、その特性や用途について理解することは非常に重要です。以下に、メチルプレドニゾロン製剤の概念を詳しく述べます。 メチルプレドニゾロンは、プレドニゾロンの誘導体であり、これにメチル基が付加された化合物です。この化合物は、内分泌系から分泌される天然のコルチコステロイドホルモンと類似の構造を持ち、強力な抗炎症作用を示します。特に、免疫系が関与するさまざまな疾患において、炎症を抑えることで症状を軽減するのに効果的です。 メチルプレドニゾロンの特徴としては、まずその速効性が挙げられます。投与後すぐに効果を発揮するため、急性の症状に対して迅速な治療が必要な場合に特に有用です。また、腎臓や肝臓に対する負担が軽減されているため、長期使用における安全性が比較的高いとされています。 メチルプレドニゾロン製剤には、数種類の製剤があります。主な形態としては、経口剤、注射剤、点眼剤などが存在します。経口剤は、患者が自宅で簡単に服用できるため、外来療法として広く利用されています。注射剤は、特に急性の症状が現れた際に、医療機関で迅速に投与されることが多いです。点眼剤は、眼に関連する疾患に対する局所治療として使用されます。 さて、これらの製剤の用途についてですが、メチルプレドニゾロンはさまざまな疾患に対して使用されます。例えば、自己免疫疾患、アレルギー反応、喘息、関節炎、皮膚疾患、神経疾患など、幅広い範囲で効果があるとされています。特に自己免疫疾患やアレルギーに由来する炎症には高い効果が期待され、これらの疾患に悩む患者さんにとっては、重要な治療薬となっています。 また、メチルプレドニゾロン製剤は、特定の病態に対する急性治療だけでなく、慢性疾患の管理にも役立ちます。例えば、慢性の喘息患者においては、急性の発作時に使用することができますし、またリウマチ性疾患においては、炎症を抑えるために定期的に投与されることもあります。このように、メチルプレドニゾロンは一時的な治療にとどまらず、長期にわたる管理に対しても優れた選択肢となっているのです。 メチルプレドニゾロンは、関連技術の進展により、その使用方法や副作用を軽減する試みが続けられています。治療の効果を高めつつ、副作用を最小化するために、徐放性製剤や点滴静脈内投与が行われることもあります。これにより、患者の生活の質を向上させ、治療効果を最大化することが目指されています。 しかし、メチルプレドニゾロンには副作用も存在します。長期使用により、感染症のリスクが高まる可能性や、骨粗鬆症、血糖値の上昇などが報告されています。そのため、使用する際には、医師の指示に従った用法・用量を守ることが重要です。また、定期的な健康診断や副作用のモニタリングが推奨されます。 メチルプレドニゾロン製剤は、特に抗炎症作用と免疫抑制作用が求められる場面で非常に有用ですが、その効果を最大限に引き出すためには、適切な使用と落ち着いた管理が必要です。医療人としては、患者に対して十分な説明を行い、治療の方針について納得してもらうことが重要です。 結論として、メチルプレドニゾロン製剤は、炎症を抑え、免疫反応を調整するための強力な医薬品であり、さまざまな疾患に対応するための必要不可欠な薬剤です。今後もその効果と安全性が更に研究され、より良い治療法が確立されることが期待されます。患者と医療従事者が協力し合い、最適な治療を提供することが、メチルプレドニゾロン製剤の利用において不可欠であると言えるでしょう。 |
